Chimeric Antigen Receptor T-Cell Therapy: A Timeline of Events and Adverse Events

As the use of CAR T-Cell therapy grows, understanding the events involved, the adverse events associated with this therapy and evidence-based management strategies is critical. Use this resource to enhance your understanding of the process behind CAR T-Cell therapy and nursing considerations associated with the treatment. 

_{This resource was developed by ONS through a sponsorship from Janssen Oncology.}

Please note that this resource is best viewed in Firefox or Safari.